Monday December 18th 2017

Sustained Improvement in Disability Outcomes with Alemtuzumab in Active Relapsing-Remitting Multiple Sclerosis Patients Who Participated in CARE-MS…

CONCLUSIONS: Alemtuzumab demonstrated a durable improvement in disability over 3 years, with the majority of patients not receiving a third course of alemtuzumab.Study Supported by: Genzyme, a Sanofi company, and Bayer Healthcare PharmaceuticalsDisclosure: Dr. Giovannoni has received personal compensation for activities with Biogen Idec, Merck Serono, Vertex Pharmaceuticals, Bayer Schering, Pfizer Inc., Teva Neuroscience, and Sanofi-Aventis Pharmaceuticals Inc. Dr. Giovannoni has received research support from Biogen Idec, Merck Serono, Novartis, and Ironwood. Dr. Margolin has received personal compensation for activities with Genzyme Corp. as an employee. Mr. Palmer has received personal compensation for activities with Genzyme Corporation as an employee. Dr. Joseph has received personal …

MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.

Visit site: 

Sustained Improvement in Disability Outcomes with Alemtuzumab in Active Relapsing-Remitting Multiple Sclerosis Patients Who Participated in CARE-MS…

Leave a Comment

More from category

MS Activists Celebrate 2017 State Policy Impact
MS Activists Celebrate 2017 State Policy Impact

/About-the-Society/News/MS-Activists-Celebrate-2017-State-Policy-Impact [Read More]

MS Research Program Funding Authorized by President Trump
MS Research Program Funding Authorized by President Trump

/About-the-Society/News/MS-Research-Program-Funding-Authorized-by-Presiden [Read More]

Germany’s Merck to make new bid to enter U.S. MS pill market
Germany’s Merck to make new bid to enter U.S. MS pill market

FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the [Read More]

Researchers develop new method for quickly detecting signs of multiple sclerosis
Researchers develop new method for quickly detecting signs of multiple sclerosis

A METHOD for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research [Read More]

Terror survivors have increased risk of frequent migraine, tension headaches
Terror survivors have increased risk of frequent migraine, tension headaches

Survivors of a terror attack have an increased risk of frequent migraine and tension headaches after the attack, [Read More]